Dr. Arvind Karena: Bridging Healing and Commerce

Surat (Gujarat) [India], January 15: Meet Dr. Arvind Karena, a dynamic entrepreneur from Umargam, whose journey from the medical field to serial exporting is rewriting the script of success. Guided by the Being Exporter program, Dr. Arvind Karena underscores the significance of mentorship in navigating the complexities of the export domain. His experience challenges the prevalent notion that export is an arduous terrain; he believes that with good mentors and guidance, it becomes an unparalleled opportunity.

Dr. Arvind Karena expressing his entrepreneurial spirit says “In the export industry, challenges are mere steppingstones to success. With the right guidance, there’s nothing better than export.” Setting ambitious goals, he aims to invest 200 CR by December 2024, showcasing that with dedication and mentorship, the entrepreneurial journey knows no bounds.

Dr. Arvind Karena’s story serves as an inspiration for emerging entrepreneurs, echoing the idea that passion, coupled with guidance, can unlock doors to uncharted territories in the world of business.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More